Cancer Gene Therapy by Viral and Non-viral Vectors
Aus der Reihe
Translational Oncology
Fr. 222.00
inkl. gesetzl. MwSt.,
Beschreibung
Produktdetails
Einband
Gebundene Ausgabe
Erscheinungsdatum
17.03.2014
Herausgeber
Malcolm Brenner + weitereVerlag
John Wiley & SonsSeitenzahl
176
Maße (L/B/H)
25.7/18.3/1.5 cm
Gewicht
590 g
Auflage
1. Auflage
Sprache
Englisch
ISBN
978-1-118-50162-7
Provides expert, state-of-the-art insight into the current progress of viral and non-viral gene therapy
Translational medicine has opened the gateway to the era of personalized or precision medicine. No longer a one-size-fits-all approach, the treatment of cancer is now based on an understanding of underlying biologic mechanisms and is increasingly being tailored to the molecular specificity of a tumor.
This book provides a comprehensive overview of the pertinent molecular discoveries in the cancer field and explains how these are being used for gene-based cancer therapies. Designed as a volume in the Translational Oncology book series, Cancer Gene Therapy by Viral and Non-viral Vectors deals with the practice of gene-therapy, with reference to vectors for gene expression and gene transfer, as well as viral therapy. It covers the history and current and future applications of gene transfer in cancer, and provides expert insight on the progress of viral and non-viral gene therapy with regard to delivery system, vector design, potential therapeutic genes, and principles and regulations for cancer gene therapy.
Presented in three parts, Cancer Gene Therapy by Viral and Non-viral Vectors covers:
Delivery Systems
* Translational Cancer Research: Gene Therapy by Viral and Non-viral Vectors
* Retroviruses for Cancer Therapy
* DNA Plasmids for Non-viral Gene Therapy of Cancer
* Cancer Therapy with RNAi delivered by Non-viral Membrane/Core Nanoparticles
Targeted Expression
* Cancer Gene Therapy by Tissue-specific and Cancer-targeting Promptors
* MicroRNAs as Drugs and Drug Targets in Cancer
Principles of Clinical Trials in Gene Therapy
* Regulatory issues for Manufacturers of Viral Vectors and Vector-transduced Cells for Phase I/II Trials
* US Regulations Governing Clinical Trials in Gene Therapy
* Remaining Obstacles to the Success of Cancer Gene Therapy
Focusing on speeding the process in clinical cancer care by bringing therapies as quickly as possible from bench to bedside, Cancer Gene Therapy by Viral and Non-viral Vectors is an absolutely vital book for physicians, clinicians, researchers, and students involved in this area of medicine.
Translational medicine has opened the gateway to the era of personalized or precision medicine. No longer a one-size-fits-all approach, the treatment of cancer is now based on an understanding of underlying biologic mechanisms and is increasingly being tailored to the molecular specificity of a tumor.
This book provides a comprehensive overview of the pertinent molecular discoveries in the cancer field and explains how these are being used for gene-based cancer therapies. Designed as a volume in the Translational Oncology book series, Cancer Gene Therapy by Viral and Non-viral Vectors deals with the practice of gene-therapy, with reference to vectors for gene expression and gene transfer, as well as viral therapy. It covers the history and current and future applications of gene transfer in cancer, and provides expert insight on the progress of viral and non-viral gene therapy with regard to delivery system, vector design, potential therapeutic genes, and principles and regulations for cancer gene therapy.
Presented in three parts, Cancer Gene Therapy by Viral and Non-viral Vectors covers:
Delivery Systems
* Translational Cancer Research: Gene Therapy by Viral and Non-viral Vectors
* Retroviruses for Cancer Therapy
* DNA Plasmids for Non-viral Gene Therapy of Cancer
* Cancer Therapy with RNAi delivered by Non-viral Membrane/Core Nanoparticles
Targeted Expression
* Cancer Gene Therapy by Tissue-specific and Cancer-targeting Promptors
* MicroRNAs as Drugs and Drug Targets in Cancer
Principles of Clinical Trials in Gene Therapy
* Regulatory issues for Manufacturers of Viral Vectors and Vector-transduced Cells for Phase I/II Trials
* US Regulations Governing Clinical Trials in Gene Therapy
* Remaining Obstacles to the Success of Cancer Gene Therapy
Focusing on speeding the process in clinical cancer care by bringing therapies as quickly as possible from bench to bedside, Cancer Gene Therapy by Viral and Non-viral Vectors is an absolutely vital book for physicians, clinicians, researchers, and students involved in this area of medicine.
Noch keine Bewertungen vorhanden
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.